Cargando…

A novel autophagy activator ginsenoside Rh2 enhances the efficacy of immunogenic chemotherapy

Detalles Bibliográficos
Autores principales: Yang, Jing, Zhang, Wei, Jia, Lin, Shi, Fei, Cao, Min, Sun, Jichao, Xu, Chengchao, Li, Zhijie, Cheng, Zhiqiang, Zhao, Shan‐Chao, Wang, Jigang, Yang, Chuanbin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9894730/
https://www.ncbi.nlm.nih.gov/pubmed/36732082
http://dx.doi.org/10.1002/ctm2.1109
_version_ 1784881799597391872
author Yang, Jing
Zhang, Wei
Jia, Lin
Shi, Fei
Cao, Min
Sun, Jichao
Xu, Chengchao
Li, Zhijie
Cheng, Zhiqiang
Zhao, Shan‐Chao
Wang, Jigang
Yang, Chuanbin
author_facet Yang, Jing
Zhang, Wei
Jia, Lin
Shi, Fei
Cao, Min
Sun, Jichao
Xu, Chengchao
Li, Zhijie
Cheng, Zhiqiang
Zhao, Shan‐Chao
Wang, Jigang
Yang, Chuanbin
author_sort Yang, Jing
collection PubMed
description
format Online
Article
Text
id pubmed-9894730
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-98947302023-02-06 A novel autophagy activator ginsenoside Rh2 enhances the efficacy of immunogenic chemotherapy Yang, Jing Zhang, Wei Jia, Lin Shi, Fei Cao, Min Sun, Jichao Xu, Chengchao Li, Zhijie Cheng, Zhiqiang Zhao, Shan‐Chao Wang, Jigang Yang, Chuanbin Clin Transl Med Letter to the Editor John Wiley and Sons Inc. 2023-02-02 /pmc/articles/PMC9894730/ /pubmed/36732082 http://dx.doi.org/10.1002/ctm2.1109 Text en © 2022 The Authors. Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Letter to the Editor
Yang, Jing
Zhang, Wei
Jia, Lin
Shi, Fei
Cao, Min
Sun, Jichao
Xu, Chengchao
Li, Zhijie
Cheng, Zhiqiang
Zhao, Shan‐Chao
Wang, Jigang
Yang, Chuanbin
A novel autophagy activator ginsenoside Rh2 enhances the efficacy of immunogenic chemotherapy
title A novel autophagy activator ginsenoside Rh2 enhances the efficacy of immunogenic chemotherapy
title_full A novel autophagy activator ginsenoside Rh2 enhances the efficacy of immunogenic chemotherapy
title_fullStr A novel autophagy activator ginsenoside Rh2 enhances the efficacy of immunogenic chemotherapy
title_full_unstemmed A novel autophagy activator ginsenoside Rh2 enhances the efficacy of immunogenic chemotherapy
title_short A novel autophagy activator ginsenoside Rh2 enhances the efficacy of immunogenic chemotherapy
title_sort novel autophagy activator ginsenoside rh2 enhances the efficacy of immunogenic chemotherapy
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9894730/
https://www.ncbi.nlm.nih.gov/pubmed/36732082
http://dx.doi.org/10.1002/ctm2.1109
work_keys_str_mv AT yangjing anovelautophagyactivatorginsenosiderh2enhancestheefficacyofimmunogenicchemotherapy
AT zhangwei anovelautophagyactivatorginsenosiderh2enhancestheefficacyofimmunogenicchemotherapy
AT jialin anovelautophagyactivatorginsenosiderh2enhancestheefficacyofimmunogenicchemotherapy
AT shifei anovelautophagyactivatorginsenosiderh2enhancestheefficacyofimmunogenicchemotherapy
AT caomin anovelautophagyactivatorginsenosiderh2enhancestheefficacyofimmunogenicchemotherapy
AT sunjichao anovelautophagyactivatorginsenosiderh2enhancestheefficacyofimmunogenicchemotherapy
AT xuchengchao anovelautophagyactivatorginsenosiderh2enhancestheefficacyofimmunogenicchemotherapy
AT lizhijie anovelautophagyactivatorginsenosiderh2enhancestheefficacyofimmunogenicchemotherapy
AT chengzhiqiang anovelautophagyactivatorginsenosiderh2enhancestheefficacyofimmunogenicchemotherapy
AT zhaoshanchao anovelautophagyactivatorginsenosiderh2enhancestheefficacyofimmunogenicchemotherapy
AT wangjigang anovelautophagyactivatorginsenosiderh2enhancestheefficacyofimmunogenicchemotherapy
AT yangchuanbin anovelautophagyactivatorginsenosiderh2enhancestheefficacyofimmunogenicchemotherapy
AT yangjing novelautophagyactivatorginsenosiderh2enhancestheefficacyofimmunogenicchemotherapy
AT zhangwei novelautophagyactivatorginsenosiderh2enhancestheefficacyofimmunogenicchemotherapy
AT jialin novelautophagyactivatorginsenosiderh2enhancestheefficacyofimmunogenicchemotherapy
AT shifei novelautophagyactivatorginsenosiderh2enhancestheefficacyofimmunogenicchemotherapy
AT caomin novelautophagyactivatorginsenosiderh2enhancestheefficacyofimmunogenicchemotherapy
AT sunjichao novelautophagyactivatorginsenosiderh2enhancestheefficacyofimmunogenicchemotherapy
AT xuchengchao novelautophagyactivatorginsenosiderh2enhancestheefficacyofimmunogenicchemotherapy
AT lizhijie novelautophagyactivatorginsenosiderh2enhancestheefficacyofimmunogenicchemotherapy
AT chengzhiqiang novelautophagyactivatorginsenosiderh2enhancestheefficacyofimmunogenicchemotherapy
AT zhaoshanchao novelautophagyactivatorginsenosiderh2enhancestheefficacyofimmunogenicchemotherapy
AT wangjigang novelautophagyactivatorginsenosiderh2enhancestheefficacyofimmunogenicchemotherapy
AT yangchuanbin novelautophagyactivatorginsenosiderh2enhancestheefficacyofimmunogenicchemotherapy